VMP 42216511000001100

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Spironolactone 25mg tablets
BNF code 0202030S0AAATAT
Virtual Therapeutic Moiety Spironolactone
Date identifier became valid 1 Sep 2023
Previous product identifier 318056008
Basis of preferred name rINN - Recommended International Non-proprietary
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 1.000
Unit dose form units tablet
Unit dose unit of measure tablet
Virtual Product Ingredient
Ingredient Spironolactone
Basis of pharmaceutical strength Based on Ingredient Substance
Strength value numerator 25.000
Strength value numerator unit mg
Ontology Drug Form & Route
Form & Route tablet.oral
Dose Form
Formulation Oral tablet
Drug Route
Route Oral
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Aldactone 25mg tablets (Pfizer Ltd)
Spironolactone 25mg tablets (A A H Pharmaceuticals Ltd)
Spironolactone 25mg tablets (Accord-UK Ltd)
Spironolactone 25mg tablets (Alliance Healthcare (Distribution) Ltd)
Spironolactone 25mg tablets (Almus Pharmaceuticals Ltd)
Spironolactone 25mg tablets (Bristol Laboratories Ltd)
Spironolactone 25mg tablets (Genesis Pharmaceuticals Ltd)
Spironolactone 25mg tablets (Key Pharmaceuticals Ltd)
Spironolactone 25mg tablets (Medihealth (Northern) Ltd)
Spironolactone 25mg tablets (Phoenix Healthcare Distribution Ltd)
Spironolactone 25mg tablets (Teva UK Ltd)
Virtual Medicinal Product Packs
Spironolactone 25mg tablets 100 tablet
Spironolactone 25mg tablets 28 tablet
Spironolactone 25mg tablets 30 tablet
Spironolactone 25mg tablets 500 tablet

dm+d data retrieved from TRUD: release NHSBSA_4.4.0_20240429000001, imported on 29th April 2024 at 05:07:25.

Feedback